| Adjuvant chemotherapy for stage II colon cancer SE Rebuzzi, G Pesola, V Martelli, AF Sobrero Cancers 12 (9), 2584, 2020 | 44 | 2020 |
| Assessing the impact of the COVID-19 outbreak on the attitudes and practice of Italian oncologists toward breast cancer care and related research activities F Poggio, M Tagliamento, M Di Maio, V Martelli, A De Maria, E Barisione, ... JCO Oncology Practice 16 (11), e1304-e1314, 2020 | 38 | 2020 |
| Targeting the DNA damage response pathway as a novel therapeutic strategy in colorectal cancer F Catalano, R Borea, S Puglisi, A Boutros, A Gandini, M Cremante, ... Cancers 14 (6), 1388, 2022 | 28 | 2022 |
| The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with radium-223 … M Bauckneht, SE Rebuzzi, A Signori, MI Donegani, V Murianni, A Miceli, ... Cancers 12 (11), 3213, 2020 | 27 | 2020 |
| Prognostic and predictive molecular biomarkers in advanced colorectal cancer V Martelli, A Pastorino, AF Sobrero Pharmacology & Therapeutics 236, 108239, 2022 | 26 | 2022 |
| How to protect ovarian function before and during chemotherapy? L Arecco, T Ruelle, V Martelli, A Boutros, MM Latocca, S Spinaci, ... Journal of Clinical Medicine 10 (18), 4192, 2021 | 26 | 2021 |
| Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study M Bersanelli, S Buti, GL Banna, UD Giorgi, A Cortellini, SE Rebuzzi, ... Immunotherapy 12 (2), 151-159, 2020 | 20 | 2020 |
| Beyond first-line immunotherapy: potential therapeutic strategies based on different pattern progressions: oligo and systemic progression A Prelaj, CC Pircher, G Massa, V Martelli, G Corrao, G Lo Russo, C Proto, ... Cancers 13 (6), 1300, 2021 | 15 | 2021 |
| The role of immunotherapy in microsatellites stable metastatic colorectal cancer: state of the art and future perspectives A Gandini, S Puglisi, C Pirrone, V Martelli, F Catalano, S Nardin, A Seeber, ... Frontiers in Oncology 13, 1161048, 2023 | 11 | 2023 |
| Clinical significance of germline pathogenic variants among 51 cancer predisposition genes in an unselected cohort of Italian pancreatic cancer patients A Puccini, M Ponzano, B Dalmasso, I Vanni, A Gandini, S Puglisi, R Borea, ... Cancers 14 (18), 4447, 2022 | 11 | 2022 |
| Comparing the gonadotoxicity of multiple breast cancer regimens: important understanding for managing breast cancer in pre-menopausal women V Martelli, MM Latocca, T Ruelle, M Perachino, L Arecco, K Beshiri, ... Breast Cancer: Targets and Therapy, 341-351, 2021 | 10 | 2021 |
| Immunotherapy retreatment: case report, review of the literature and proposal for the definition of different scenarios R Borea, A Damassi, SE Rebuzzi, GL Banna, V Murianni, F Catalano, ... Immunotherapy 13 (8), 645-652, 2021 | 6 | 2021 |
| Baseline lymphocyte to monocyte ratio (LMR) and systemic inflammation index (SII) as prognostic factors in metastatic renal cell carcinoma (mRCC) patients treated with … SE Rebuzzi, S Buti, A Sbrana, G Procopio, U De Giorgi, MG Vitale, ... Journal of Clinical Oncology 38 (6_suppl), 751-751, 2020 | 6 | 2020 |
| ctDNA to guide treatment of colorectal cancer: ready for standard of care? A Puccini, V Martelli, A Pastorino, S Sciallero, A Sobrero Current Treatment Options in Oncology 24 (2), 76-92, 2023 | 5 | 2023 |
| Pyrotinib: a new promising targeted agent for human epidermal growth factor receptor 2-positive breast cancer M Perachino, L Arecco, V Martelli, M Lambertini Translational Breast Cancer Research 1, 2020 | 4 | 2020 |
| Gastrointestinal stromal tumors and second primary malignancies: a retrospective monocentric analysis. D Comandini, M Grassi, A Prelaj, V Martelli, A Damiani, G Damiano, ... Neoplasma 67 (6), 2020 | 3 | 2020 |
| Reliability of patient-reported toxicities during adjuvant chemotherapy M Cremante, A Pastorino, M Ponzano, M Grassi, V Martelli, A Puccini, ... European Journal of Cancer 182, 115-121, 2023 | 2 | 2023 |
| Baseline and early change of neutrophil to lymphocyte ratio (bNLR and ΔNLR) as prognostic factors in metastatic renal cell carcinoma (mRCC) treated with Nivolumab: Final … SE Rebuzzi, S Buti, M Maruzzo, U De Giorgi, A Sbrana, PA Zucali, ... Journal of Clinical Oncology 38 (15_suppl), e17081-e17081, 2020 | 2 | 2020 |
| Streamlining the diagnostic pathway for Lynch syndrome in colorectal cancer patients: a 10-year experience in a single Italian Cancer Center A Puccini, S Nardin, L Trevisan, S Lastraioli, V Gismondi, I Ricciotti, ... European Journal of Cancer Prevention 33 (4), 355-362, 2024 | 1 | 2024 |
| Indagine trasversale sull’attività dei centri di Cardiochirurgia nell’ambito del ‘Progetto BPAC’(esiti a breve termine di interventi di bypass aortocoronarico nelle … F Seccareccia, P Capriani, S Diemoz, E Taioli, ME Tosti, D Greco Ital Heart J Suppl 4 (1), 32-8, 2003 | 1 | 2003 |
